Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks.

Saadah NH, Schipperus MR, Wiersum-Osselton JC, van Kraaij MG, Caram-Deelder C, Beckers EAM, Leyte A, Rondeel JMM, de Vooght KMK, Weerkamp F, Zwaginga JJ, van der Bom JG.

Haematologica. 2019 Jul 4. pii: haematol.2019.222083. doi: 10.3324/haematol.2019.222083. [Epub ahead of print]

2.

Comparison of outcome between intrauterine balloon tamponade and uterine artery embolization in the management of persistent postpartum hemorrhage: A propensity score-matched cohort study.

Ramler PI, Henriquez DDCA, van den Akker T, Caram-Deelder C, Groenwold RHH, Bloemenkamp KWM, van Roosmalen J, van Lith JMM, van der Bom JG; TeMpOH-1 study group.

Acta Obstet Gynecol Scand. 2019 Jun 26. doi: 10.1111/aogs.13679. [Epub ahead of print]

PMID:
31240693
3.

[Anaemia in hospital patients: transfusion or not?]

van der Bom JG.

Ned Tijdschr Geneeskd. 2019 May 22;163. pii: D3873. Dutch.

PMID:
31166099
4.

Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3 months after birth.

Ree IMC, de Haas M, Middelburg RA, Zwiers C, Oepkes D, van der Bom JG, Lopriore E.

Br J Haematol. 2019 Aug;186(4):565-573. doi: 10.1111/bjh.15962. Epub 2019 May 29.

PMID:
31140599
5.

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease.

Atiq F, Fijnvandraat K, van Galen KPM, Laros-Van Gorkom BAP, Meijer K, de Meris J, Coppens M, Mauser-Bunschoten EP, Cnossen MH, van der Bom JG, Eikenboom J, Leebeek FWG; WiN study group.

Am J Hematol. 2019 Aug;94(8):E201-E205. doi: 10.1002/ajh.25499. Epub 2019 May 13. No abstract available.

PMID:
31037771
6.

Predictive value of a bleeding score for postpartum hemorrhage.

Gillissen A, van den Akker T, Caram-Deelder C, Henriquez DDCA, Nij Bijvank SWA, Bloemenkamp KWM, Eikenboom J, van der Bom JG.

Res Pract Thromb Haemost. 2019 Apr 4;3(2):277-284. doi: 10.1002/rth2.12194. eCollection 2019 Apr.

7.

Mortality of patients with haemophilia in Brazil: First report.

Jardim LL, van der Bom JG, Caram-Deelder C, Gouw SC, Leal Cherchiglia M, Meireles Rezende S.

Haemophilia. 2019 May;25(3):e146-e152. doi: 10.1111/hae.13730. Epub 2019 Mar 15.

PMID:
30875453
8.

Dynamic prediction of bleeding risk in thrombocytopenic preterm neonates.

Fustolo-Gunnink SF, Fijnvandraat K, Putter H, Ree IM, Caram-Deelder C, Andriessen P, d'Haens EJ, Hulzebos CV, Onland W, Kroon AA, Vijlbrief DC, Lopriore E, van der Bom JG.

Haematologica. 2019 Feb 28. pii: haematol.2018.208595. doi: 10.3324/haematol.2018.208595. [Epub ahead of print]

9.

Fluid resuscitation during persistent postpartum haemorrhage and maternal outcome: A nationwide cohort study.

Henriquez DDCA, Bloemenkamp KWM, Loeff RM, Zwart JJ, van Roosmalen JJM, Zwaginga JJ, van der Bom JG; TeMpOH-1 study group.

Eur J Obstet Gynecol Reprod Biol. 2019 Apr;235:49-56. doi: 10.1016/j.ejogrb.2019.01.027. Epub 2019 Feb 4.

PMID:
30784827
10.

Comparison of thromboelastometry by ROTEM® Delta and ROTEM® Sigma in women with postpartum haemorrhage.

Gillissen A, van den Akker T, Caram-Deelder C, Henriquez DDCA, Bloemenkamp KWM, Eikenboom J, van der Bom JG, de Maat MPM.

Scand J Clin Lab Invest. 2019 Feb - Apr;79(1-2):32-38. doi: 10.1080/00365513.2019.1571220. Epub 2019 Feb 6.

PMID:
30727759
11.

Women receiving massive transfusion due to postpartum hemorrhage: A comparison over time between two nationwide cohort studies.

Ramler PI, van den Akker T, Henriquez DDCA, Zwart JJ, van Roosmalen J, van Lith JMM, van der Bom JG; TeMpOH-1 study group.

Acta Obstet Gynecol Scand. 2019 Jun;98(6):795-804. doi: 10.1111/aogs.13542. Epub 2019 Feb 11.

12.

Sports participation and physical activity in patients with von Willebrand disease.

Atiq F, Mauser-Bunschoten EP, Eikenboom J, van Galen KPM, Meijer K, de Meris J, Cnossen MH, Beckers EAM, Laros-van Gorkom BAP, Nieuwenhuizen L, van der Bom JG, Fijnvandraat K, Leebeek FWG; WiN study group.

Haemophilia. 2019 Jan;25(1):101-108. doi: 10.1111/hae.13629. Epub 2018 Nov 14.

PMID:
30427095
13.

The prevalence and burden of hand and wrist bleeds in von Willebrand disease.

van Deukeren D, Mauser-Bunschoten EP, Schutgens REG, Eikenboom J, Meijer K, Fijnvandraat K, Laros-van Gorkom BAP, Cnossen M, de Meris J, van der Bom JG, Leebeek FWG, van Galen KPM.

Haemophilia. 2019 Jan;25(1):e35-e38. doi: 10.1111/hae.13632. Epub 2018 Nov 5. No abstract available.

PMID:
30394622
14.

Clinically relevant differences between assays for von Willebrand factor activity.

Boender J, Eikenboom J, van der Bom JG, Meijer K, de Meris J, Fijnvandraat K, Cnossen MH, Laros-van Gorkom BAP, van Heerde WL, Mauser-Bunschoten EP, de Maat MPM, Leebeek FWG; WiN Study Group.

J Thromb Haemost. 2018 Dec;16(12):2413-2424. doi: 10.1111/jth.14319. Epub 2018 Nov 20.

PMID:
30358069
15.

Aspirin intake in the morning is associated with suboptimal platelet inhibition, as measured by serum Thromboxane B2, during infarct-prone early-morning hours.

Racca C, van Diemen JJK, Fuijkschot WW, Spit K, Bonten TN, Numans ME, van der Bom JG, Smulders YM, Thijs A.

Platelets. 2018 Oct 22:1-7. doi: 10.1080/09537104.2018.1528347. [Epub ahead of print]

PMID:
30346860
16.

Personalization of medicine requires better observational evidence.

Middelburg RA, Arbous MS, Middelburg JG, van der Bom JG.

Clin Epidemiol. 2018 Oct 3;10:1391-1399. doi: 10.2147/CLEP.S167137. eCollection 2018.

17.

Are thrombocytopenia and platelet transfusions associated with major bleeding in preterm neonates? A systematic review.

Fustolo-Gunnink SF, Huisman EJ, van der Bom JG, van Hout FMA, Makineli S, Lopriore E, Fijnvandraat K.

Blood Rev. 2019 Jul;36:1-9. doi: 10.1016/j.blre.2018.10.001. Epub 2018 Oct 9. Review.

PMID:
30318111
18.

Association between fluid management and dilutional coagulopathy in severe postpartum haemorrhage: a nationwide retrospective cohort study.

Gillissen A, van den Akker T, Caram-Deelder C, Henriquez DDCA, Bloemenkamp KWM, van Roosmalen JJM, Eikenboom J, van der Bom JG; TeMpOH-1 study group.

BMC Pregnancy Childbirth. 2018 Oct 11;18(1):398. doi: 10.1186/s12884-018-2021-9.

19.

Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study.

Gillissen A, van den Akker T, Caram-Deelder C, Henriquez DDCA, Bloemenkamp KWM, de Maat MPM, van Roosmalen JJM, Zwart JJ, Eikenboom J, van der Bom JG; TeMpOH-1 Study Group.

Blood Adv. 2018 Oct 9;2(19):2433-2442. doi: 10.1182/bloodadvances.2018022632.

20.

Prospective validation of the EuroSCORE II risk model in a single Dutch cardiac surgery centre.

Hogervorst EK, Rosseel PMJ, van de Watering LMG, Brand A, Bentala M, van der Meer BJM, van der Bom JG.

Neth Heart J. 2018 Nov;26(11):540-551. doi: 10.1007/s12471-018-1161-x.

21.

Defining patient value in haemophilia care.

van Balen EC, Gouw SC, Hazelzet JA, van der Bom JG, Cnossen MH.

Haemophilia. 2018 Jul;24(4):516-518. doi: 10.1111/hae.13550. No abstract available.

PMID:
30141573
22.

The identification of cases of major hemorrhage during hospitalization in patients with acute leukemia using routinely recorded healthcare data.

Kreuger AL, Middelburg RA, Beckers EAM, de Vooght KMK, Zwaginga JJ, Kerkhoffs JH, van der Bom JG.

PLoS One. 2018 Aug 15;13(8):e0200655. doi: 10.1371/journal.pone.0200655. eCollection 2018.

23.

Preventing or Eradicating Factor VIII Antibody Formation in Patients with Hemophilia A: What Can We Learn from Other Disorders?

Hassan S, Fijnvandraat K, van der Bom JG, Gouw SC.

Semin Thromb Hemost. 2018 Sep;44(6):531-543. doi: 10.1055/s-0038-1666823. Epub 2018 Jul 25. Review.

PMID:
30045390
24.

The effect of a fibrin sealant on knee function after total knee replacement surgery. Results from the FIRST trial. A multicenter randomized controlled trial.

Verra WC, van Hilten JA, Honohan Á, van Zwet EW, van der Bom JG, Nelissen RGHH; FIRST-research group.

PLoS One. 2018 Jul 25;13(7):e0200804. doi: 10.1371/journal.pone.0200804. eCollection 2018.

25.

Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.

Zwiers C, van der Bom JG, van Kamp IL, van Geloven N, Lopriore E, Smoleniec J, Devlieger R, Sim PE, Ledingham MA, Tiblad E, Moise KJ Jr, Gloning KP, Kilby MD, Overton TG, Jørgensen DS, Schou KV, Paek B, Walker M, Parry E, Oepkes D, de Haas M.

Am J Obstet Gynecol. 2018 Sep;219(3):291.e1-291.e9. doi: 10.1016/j.ajog.2018.06.007. Epub 2018 Jun 11.

PMID:
29902448
26.

Management of postpartum hemorrhage: how to improve maternal outcomes?

Henriquez DDCA, Bloemenkamp KWM, van der Bom JG.

J Thromb Haemost. 2018 Jun 8. doi: 10.1111/jth.14200. [Epub ahead of print] Review.

PMID:
29883040
27.

Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial.

van der Meer PF, Ypma PF, van Geloven N, van Hilten JA, van Wordragen-Vlaswinkel RJ, Eissen O, Zwaginga JJ, Trus M, Beckers EAM, Te Boekhorst P, Tinmouth A, Lin Y, Hsia C, Lee D, Norris PJ, Goodrich RP, Brand A, Hervig T, Heddle NM, van der Bom JG, Kerkhoffs JH.

Blood. 2018 Jul 12;132(2):223-231. doi: 10.1182/blood-2018-02-831289. Epub 2018 May 17.

28.

Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.

Atiq F, Meijer K, Eikenboom J, Fijnvandraat K, Mauser-Bunschoten EP, van Galen KPM, Nijziel MR, Ypma PF, de Meris J, Laros-van Gorkom BAP, van der Bom JG, de Maat MP, Cnossen MH, Leebeek FWG; WiN study group.

Br J Haematol. 2018 Jul;182(1):93-105. doi: 10.1111/bjh.15277. Epub 2018 May 16.

29.

Thrombocytopenia and bleeding in myelosuppressed transfusion-dependent patients: a simulation study exploring underlying mechanisms.

Middelburg RA, Kerkhoffs JH, van der Bom JG.

Clin Epidemiol. 2018 Apr 11;10:401-411. doi: 10.2147/CLEP.S149926. eCollection 2018.

30.

Treatment and outcomes of fetal/neonatal alloimmune thrombocytopenia: a nationwide cohort study in newly detected cases.

Winkelhorst D, Oostweegel M, Porcelijn L, Middelburg RA, Zwaginga JJ, Oepkes D, van der Bom JG, de Haas M, Lopriore E.

Br J Haematol. 2019 Mar;184(6):1026-1029. doi: 10.1111/bjh.15216. Epub 2018 Apr 16. No abstract available.

PMID:
29682737
31.

Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review.

Hassan S, Cannavò A, Gouw SC, Rosendaal FR, van der Bom JG.

J Thromb Haemost. 2018 Jun;16(6):1055-1068. doi: 10.1111/jth.14124. Epub 2018 May 24.

PMID:
29665204
32.

Ever-Pregnant Female Blood Donors and Mortality Risk in Male Recipients-Reply.

Middelburg RA, Caram-Deelder C, van der Bom JG.

JAMA. 2018 Mar 13;319(10):1049. doi: 10.1001/jama.2017.21872. No abstract available.

PMID:
29536095
33.

Variation in red cell transfusion decisions in the intensive care unit - a nationwide survey in the Netherlands.

Kranenburg FJ, Willems SA, Le Cessie S, Marang-van de Mheen PJ, van der Bom JG, Arbous MS.

Vox Sang. 2018 May;113(4):378-385. doi: 10.1111/vox.12639. Epub 2018 Feb 23.

PMID:
29473174
34.

Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.

van Hout FMA, van der Meer PF, Wiersum-Osselton JC, Middelburg RA, Schipperus MR, van der Bom JG, Kerkhoffs JL.

Transfusion. 2018 Apr;58(4):1021-1027. doi: 10.1111/trf.14509. Epub 2018 Feb 6.

PMID:
29405304
35.

Influence of pre-analytical time and temperature conditions on serum thromboxane B2 levels.

van Diemen JJK, Fuijkschot WW, Spit K, van Reuler AVR, Bonten TN, Numans ME, van der Bom JG, Smulders YM, Thijs A.

Thromb Res. 2018 Mar;163:1-5. doi: 10.1016/j.thromres.2018.01.010. Epub 2018 Jan 6. No abstract available.

PMID:
29324331
36.

Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.

Saadah NH, van der Bom JG, Wiersum-Osselton JC, Richardson C, Middelburg RA, Politis C, Renaudier P, Robillard P, Schipperus MR.

Br J Haematol. 2018 Mar;180(5):727-734. doi: 10.1111/bjh.15082. Epub 2018 Jan 9.

PMID:
29318576
37.

Desmopressin in moderate hemophilia A patients: a treatment worth considering.

Loomans JI, Kruip MJHA, Carcao M, Jackson S, van Velzen AS, Peters M, Santagostino E, Platokouki H, Beckers E, Voorberg J, van der Bom JG, Fijnvandraat K; RISE consortium.

Haematologica. 2018 Mar;103(3):550-557. doi: 10.3324/haematol.2017.180059. Epub 2018 Jan 5.

38.

Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study.

Groeneveld DJ, Sanders YV, Adelmeijer J, Mauser-Bunschoten EP, van der Bom JG, Cnossen MH, Fijnvandraat K, Laros-van Gorkom BAP, Meijer K, Lisman T, Eikenboom J, Leebeek FWG.

Thromb Haemost. 2018 Jan;118(1):152-160. doi: 10.1160/TH17-06-0397. Epub 2018 Jan 5.

PMID:
29304535
39.

Storage time of platelet concentrates and risk of a positive blood culture: a nationwide cohort study.

Kreuger AL, Rostgaard K, Middelburg RA, Kerkhoffs JH, Edgren G, Erikstrup C, Pedersen OB, Titlestad K, Nielsen KR, Ostrowski SR, Voldstedlund M, van der Bom JG, Ullum H, Hjalgrim H.

Transfusion. 2018 Jan;58(1):16-24. doi: 10.1111/trf.14401. Epub 2017 Nov 22.

PMID:
29168187
40.

The effect of tranexamic acid on blood loss and maternal outcome in the treatment of persistent postpartum hemorrhage: A nationwide retrospective cohort study.

Gillissen A, Henriquez DDCA, van den Akker T, Caram-Deelder C, Wind M, Zwart JJ, van Roosmalen J, Eikenboom J, Bloemenkamp KWM, van der Bom JG; TeMpOH-1 study group.

PLoS One. 2017 Nov 6;12(11):e0187555. doi: 10.1371/journal.pone.0187555. eCollection 2017.

41.

Age of platelet concentrates and time to the next transfusion.

Caram-Deelder C, van der Bom JG, Putter H, Leyte A, Kerkhof DV, Evers D, Beckers EA, Weerkamp F, Hudig F, Zwaginga JJ, Rondeel JMM, de Vooght KMK, Péquériaux NCV, Visser O, Wallis JP, Middelburg RA.

Transfusion. 2018 Jan;58(1):121-131. doi: 10.1111/trf.14388. Epub 2017 Oct 31.

PMID:
29090466
42.

Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients.

Caram-Deelder C, Kreuger AL, Evers D, de Vooght KMK, van de Kerkhof D, Visser O, Péquériaux NCV, Hudig F, Zwaginga JJ, van der Bom JG, Middelburg RA.

JAMA. 2017 Oct 17;318(15):1471-1478. doi: 10.1001/jama.2017.14825. Erratum in: JAMA. 2018 Feb 20;319(7):724.

43.

Viscoelastometric testing, fibrinogen and transfusion during post-partum haemorrhage.

van der Bom JG.

Br J Anaesth. 2017 Sep 1;119(3):352-353. doi: 10.1093/bja/aex168. No abstract available.

44.

Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study.

Jardim LL, Chaves DG, Silveira-Cassette ACO, Simões E Silva AC, Santana MP, Cerqueira MH, Prezotti A, Lorenzato C, Franco V, van der Bom JG, Rezende SM.

Br J Haematol. 2017 Sep;178(6):971-978. doi: 10.1111/bjh.14799. Epub 2017 Aug 23.

PMID:
28836262
45.

Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis/regression.

Saadah NH, van Hout FMA, Schipperus MR, le Cessie S, Middelburg RA, Wiersum-Osselton JC, van der Bom JG.

Transfusion. 2017 Sep;57(9):2104-2114. doi: 10.1111/trf.14245. Epub 2017 Aug 2. Review.

PMID:
28766723
46.

Effect of solvent/detergent-treated pooled plasma on fibrinolysis in reconstituted whole blood.

Saadah NH, van der Meer PF, Brinkman HJM, de Korte D, Bontekoe IJ, Korsten HH, Middelburg RA, van der Bom JG, Schipperus MR.

Transfusion. 2017 Oct;57(10):2381-2389. doi: 10.1111/trf.14260. Epub 2017 Jul 20.

PMID:
28727139
47.

Chronic use of low-dose aspirin is not associated with lower bone mineral density in the general population.

Bonten TN, de Mutsert R, Rosendaal FR, Jukema JW, van der Bom JG, de Jongh RT, den Heijer M.

Int J Cardiol. 2017 Oct 1;244:298-302. doi: 10.1016/j.ijcard.2017.06.089. Epub 2017 Jun 27.

PMID:
28673738
48.

Storage time of platelet concentrates and all-cause bacteremia in hematologic patients.

Kreuger AL, Middelburg RA, Bank CMC, Beckers EAM, van Gammeren AJ, Leyte A, Rondeel JMM, de Vooght KMK, Weerkamp F, Zwaginga JJ, Kerkhoffs JLH, van der Bom JG.

Transfusion. 2017 Sep;57(9):2096-2103. doi: 10.1111/trf.14194. Epub 2017 Jun 26.

PMID:
28653425
49.

Relative risk of hemorrhage during pregnancy in patients with brain arteriovenous malformations.

van Beijnum J, Wilkinson T, Whitaker HJ, van der Bom JG, Algra A, Vandertop WP, van den Berg R, Brouwer PA, Rinkel GJ, Kappelle LJ, Al-Shahi Salman R; Scottish Audit of Intracranial Vascular Malformations collaborators, Klijn CJ.

Int J Stroke. 2017 Oct;12(7):741-747. doi: 10.1177/1747493017694387. Epub 2017 Feb 27.

PMID:
28635373
50.

Comparison of haemostatic function of PAS-C-platelets vs. plasma-platelets in reconstituted whole blood using impedance aggregometry and thromboelastography.

van Hout FMA, Bontekoe IJ, de Laleijne LAE, Kerkhoffs JL, de Korte D, Eikenboom J, van der Bom JG, van der Meer PF.

Vox Sang. 2017 Aug;112(6):549-556. doi: 10.1111/vox.12534. Epub 2017 Jun 9.

PMID:
28597485

Supplemental Content

Loading ...
Support Center